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Abstract
OBJECTIVES: This study was designed to determine whether multislice computed tomography
(MSCT) coronary angiography has incremental prognostic value over single-photon emission computed
tomography myocardial perfusion imaging (MPI) in patients with suspected coronary artery disease
(CAD). BACKGROUND: Although MSCT is used for the detection of CAD in addition to MPI, its
incremental prognostic value is unclear. METHODS: In 541 patients (59% male, age 59 +/- 11 years)
referred for further cardiac evaluation, both MSCT and MPI were performed. The following events were
recorded: all-cause death, nonfatal infarction, and unstable angina requiring revascularization.
RESULTS: In the 517 (96%) patients with an interpretable MSCT, significant CAD (MSCT > or =50%
stenosis) was detected in 158 (31%) patients, and abnormal perfusion (summed stress score [SSS]: > or
=4) was observed in 168 (33%) patients. During follow-up (median 672 days; 25th, 75th percentile: 420,
896), an event occurred in 23 (5.2%) patients. After correction for baseline characteristics in a
multivariate model, MSCT emerged as an independent predictor of events with an incremental
prognostic value to MPI. The annualized hard event rate (all-cause mortality and nonfatal infarction) in
patients with none or mild CAD (MSCT <50% stenosis) was 1.8% versus 4.8% in patients with
significant CAD (MSCT > or =50% stenosis). A normal MPI (SSS <4) and abnormal MPI (SSS > or
=4) were associated with an annualized hard event rate of 1.1% and 3.8%, respectively. Both MSCT and
MPI were synergistic, and combined use resulted in significantly improved prediction (log-rank test p
value <0.005). CONCLUSIONS: MSCT is an independent predictor of events and provides incremental
prognostic value to MPI. Combined anatomical and functional assessment may allow improved risk
stratification.
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Abstract 
Objectives: To study whether multi-slice computed tomography coronary angiography 
(MSCT) has incremental prognostic value over single photon emission computed 
tomography (SPECT) myocardial perfusion imaging (MPI) in patients with suspected 
coronary artery disease (CAD). 
Background: Although MSCT is used for the detection of (CAD) in addition to MPI, its 
incremental prognostic value is unclear. 
Methods: In 541 patients (59% male, age 59±11years) referred for further cardiac 
evaluation, both MSCT and MPI were performed. The following events were recorded: 
all cause death, non-fatal infarction, and unstable angina requiring revascularization. 
Results: In the 517 (96%) patients with an interpretable MSCT, significant CAD (MSCT 
≥50% stenosis) was detected in 158 (31%) patients, while abnormal perfusion (SSS≥4) 
was observed in 168 (33%) patients. During follow-up (median 672 days, 25-75th 
percentile:420-896), an event occurred in 23 (5.2%) patients. After correction for 
baseline characteristics in a multivariate model, MSCT emerged as an independent 
predictor of events with an incremental prognostic value to MPI. The annualized hard 
event rate (all-cause mortality and non-fatal infarction) in patients with none or mild CAD 
(MSCT <50% stenosis) was 1.8% versus 4.8% in patients with significant CAD (MSCT 
≥50% stenosis). A normal MPI (SSS<4) and abnormal MPI (SSS≥4) were associated 
with an annualized hard event rate of 1.1% and 3.8% respectively. MSCT and MPI were 
synergistic and combined use resulted in significantly improved prediction (Log-rank test 
p-value<0.005). 
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Conclusions: MSCT is an independent predictor of events and provides incremental 
prognostic value to MPI. Combined anatomical and functional assessment may allow 
improved risk stratification. 
Keywords: imaging, atherosclerosis, perfusion, and prognosis. 
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Condensed abstract 
The purpose of this study was to assess the incremental prognostic value of multi-slice 
computed tomography coronary angiography (MSCT) over single photon emission 
computed tomography (SPECT) in patients with suspected coronary artery disease 
(CAD). The annualized hard event rate in patients with none or mild CAD (MSCT <50% 
stenosis) was 1.8% versus 4.8% in patients with significant CAD (MSCT ≥50% 
stenosis). A normal (SSS <4) and abnormal SPECT (SSS ≥4) were associated with an 
annualized hard event rate of 1.1% and 3.8% respectively. After correction for baseline 
characteristics, MSCT emerged as an independent predictor of events with an 
incremental prognostic value to SPECT. 
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Abbreviations list 
 
CAD  coronary artery disease 
CS  coronary artery calcium score 
ECG  electrocardiogram 
MPI  myocardial perfusion imaging 
MSCT  multi-slice computed tomography 
SPECT single photon emission computed tomography 
SDS  summed difference score 
SRS  summed rest score 
SSS  summed stress score
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Introduction 
With the arrival of multi-slice computed tomography coronary angiography (MSCT), the 
focus of non-invasive imaging has shifted from functional imaging to a combination of 
both anatomical and functional imaging. Several studies have addressed the 
association between the anatomical and functional information obtained with MSCT and 
myocardial perfusion imaging (MPI) using single photon emission computed 
tomography (SPECT) respectively.(1-3) These comparative studies have shown that 
MSCT may provide complementary rather than overlapping diagnostic information when 
used in combination with MPI. Whether MSCT provides complementary information to 
MPI with regard to risk stratification remains to be determined. Interestingly, studies in 
the past have shown that MPI provides substantial incremental value over anatomical 
information obtained with invasive coronary angiography. However no studies have 
addressed this issue more recently .(4, 5) Moreover, MSCT may have an important 
advantage over invasive coronary angiography due to its ability to provide information 
on plaque composition in addition to stenosis severity.(6) Accordingly, the information 
obtained by MSCT may potentially enhance risk stratification by MPI. The aim of this 
study was therefore to assess in patients presenting with suspected coronary artery 
disease (CAD) whether MSCT has incremental prognostic value over MPI.
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Methods 
 
Patient selection 
The study population consisted of 541 patients who prospectively underwent both MPI 
and MSCT within 3 months of each other. Enrollment of patients started in June 2003 
and continued until December 2007. Follow-up information was obtained from the start 
of the study until August 2008. Patients were included at the University Hospital in 
Zurich, Switzerland (n=269); the Cardiovascular Center in Aalst, Belgium (n=17); and at 
the Leiden University Medical Center, The Netherlands (n=255). Patients were referred 
because of chest pain complaints, a positive exercise ECG test, or a high risk profile for 
cardiovascular disease. Exclusion criteria were: cardiac arrhythmias, renal insufficiency 
(serum creatinine >120 mmol/L), known hypersensitivity to iodine contrast media, and 
pregnancy. In addition, patients with a cardiac event in the period between MSCT and 
MPI, or an uninterpretable MSCT scan were excluded. The pre-test probability of CAD 
was determined using the Diamond and Forrester method, as previously described.(7) 
The study was approved by the local ethics committees in all 3 participating centers and 
informed consent was obtained in all patients. 
 
Myocardial perfusion imaging 
Myocardial perfusion imaging was performed using gated SPECT. Two ECG-gated MPI 
protocols were used. A total of 272 patients underwent a 2-day gated stress-rest MPI 
using technetium-99m tetrofosmin (500 MBq), or technetium-99m sestamibi (500 MBq) 
with either a symptom limited bicycle test or pharmacological stress using adenosine 
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(140 mcg/kg/min for 6 minutes) or dobutamine (up to 40 mcg/kg/min in 15 min). The 
remaining 269 patients underwent a 1-day stress-rest protocol with adenosine stress 
(140 mcg/kg/min during 7 minutes) using technetium-99m tetrofosmin (300 MBq at peak 
stress and 900 MBq at rest). 
The images were acquired on a triple-head SPECT camera (GCA 9300/HG, 
Toshiba Corp., Tokyo, Japan) or a dual-head detector camera (Millennium VG & 
Hawkeye, General Electric Medical Systems, Milwaukee, WI, USA; or Vertex Epic 
ADAC Pegasus, Philips Medical Systems, Eindhoven, the Netherlands). All cameras 
were equipped with low energy high resolution collimators. A 20% window was used 
around the 140-keV energy peak of technetium-99m, and data were stored in a 64x64 
matrix. 
 Stress and rest SPECT perfusion datasets were quantitatively evaluated using 
previously validated automated software.(8) The myocardium was divided into a 20 
segment model and for each segment myocardial perfusion was evaluated using a 
standard 5-point scoring system. The segmental perfusion scores during stress and rest 
were added together to calculate the summed stress score (SSS) and the summed rest 
score (SRS). The summed difference score (SDS) was calculated by subtracting the 
SRS from the SSS. Abnormal MPI was defined as SSS≥4 and severely abnormal MPI 
was defined as SSS≥8. 
 
 
 
MSCT coronary angiography 
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In 33 patients the MSCT examination was performed using a 16-slice scanner 
(Aquillion16, Toshiba Medical Systems, Tokyo, Japan). The remaining 508 (94%) 
patients were scanned using a 64-slice MSCT scanner (Aquillion64, Toshiba Medical 
Systems, Tokyo, Japan; General Electrics LightSpeed VCT, Milwaukee, WI, US; or 
Sensation64, Siemens, Forchheim, Germany). Patient’s heart rate and blood pressure 
were monitored before each scan. In the absence of contraindications, patients with a 
heart rate exceeding the threshold of 65 beats per minute were administered beta-
blocking medication (50-100 mg metoprolol, oral or 5-10 mg metoprolol, intravenous). 
Before the helical scan, a non-enhanced low dose prospective ECG-gated scan, 
prospectively triggered at 75% of the R-R interval was performed to measure the 
coronary calcium score (CS). The helical scan parameters have been previously 
described.(3, 9) 
 Post-processing of the MSCT and CS scans was performed on dedicated 
workstations (Vitrea2, Vital Images, USA; Advantage, GE healthcare, USA; Syngo 
InSpace4D application, Siemens, Germany; and Aquarius, TeraRecon, USA). The CS 
was calculated using the Agatston method. Coronary anatomy was assessed in a 
standardized manner by dividing the coronary artery tree into 17 segments according to 
the modified American Heart Association classification. For each segment both the 
presence of atherosclerotic plaque as well as its composition was determined. 
Atherosclerotic lesions were deemed significant if the diameter stenosis was ≥50%. 
Lesions below this threshold were considered to be non-significant or mild. Plaque 
composition was graded as non-calcified plaque (plaques having lower density 
compared with the contrast-enhanced lumen), calcified plaque (plaques with high 
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density), and mixed plaque (containing elements from both non-calcified and calcified 
plaque). 
 
Follow-up 
Patient follow-up data were gathered by three observers blinded to the baseline MSCT 
and MPI results using clinical visits or standardized telephone interviews. The following 
events were regarded as clinical endpoints: all cause mortality, non-fatal myocardial 
infarction, and unstable angina requiring revascularization. Non-fatal infarction was 
defined based on criteria of typical chest pain, elevated cardiac enzyme levels, and 
typical changes on the ECG. Unstable angina was defined according to the European 
Society of Cardiology guidelines as acute chest pain with or without the presence of 
ECG abnormalities, and negative cardiac enzyme levels.(10) Patients with stable 
complaints undergoing an early elective revascularization within 60 days after imaging 
with MSCT or MPI were excluded from the survival analysis. Annualized event rates 
were calculated based on events per patient year follow-up. 
 
Statistical analysis 
Continuous variables were expressed as mean and standard deviation, and categorical 
baseline data were expressed in numbers and percentages. Cox regression analysis 
was used to determine the prognostic value of CS, MSCT, and MPI variables. First 
univariate analysis of baseline characteristics, CS, MSCT and MPI variables was 
performed using a composite endpoint of all cause mortality, non-fatal infarction, and 
unstable angina requiring revascularization. For each variable a hazard ratio with a 
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95%-confidence interval (95%-CI) was calculated. Using univariate analysis, optimal 
cutoffs (based on the number of segments affected) were created for plaque 
composition on MSCT. Finally multivariate models were created correcting MSCT and 
MPI for baseline risk factors. The incremental value of MSCT over baseline clinical 
variables and MPI was assessed by calculating the global chi-square. 
Cumulative event rates for MSCT, MPI, and for MSCT and MPI combined were 
obtained by the Kaplan-Meier method using a composite endpoint of all cause mortality, 
non-fatal infarction, and unstable angina requiring revascularization, and a hard 
composite endpoint of all cause mortality and non-fatal infarction. Statistical analyses 
were performed using SPSS software (version 12.0, SPSS Inc, Chicago, IL, USA) and 
SAS software (The SAS system 6.12, Cary, NC, USA: SAS Institute Inc). A p-value 
<0.05 was considered statistically significant.
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Results 
 
Patient characteristics 
In the study population of 541 patients an uninterpretable MSCT examination was 
present in 24 patients (4%). Reasons for uninterpretability were the presence of motion 
artifacts, increased noise due to high body mass index, and breathing. In patients with 
an uninterpretable MSCT, MPI was abnormal (SSS≥4) in 9 (38%) patients and normal 
(SSS>4) in the remaining 15 (62%) patients. After exclusion of these patients, a total of 
517 patients remained for analysis. A complete overview of the baseline characteristics 
of these patients is presented in Table 1. The average age of the study cohort was 
59±11 years and 59% of patients were men. The majority of patients (65%) presented 
with an intermediate pre-test probability for of CAD, and a low or a high probability was 
present in respectively 22% and 13% of patients. 
 
MSCT and SPECT results 
An exercise test was performed in 88 patients (17%), while pharmacological stress with 
adenosine was used in 397 patients (77%), and with dobutamine in 30 patients (6%). All 
MPI results are listed in Table 2. The gated SPECT images during rest and stress were 
normal (SSS <4) in 349 (67%) patients. An abnormal MPI (SSS≥4) was present in 192 
(33%) patients and severely abnormal MPI (SSS≥8) was present in 64 (13%) patients. 
During MSCT image acquisition, an average heart rate of 63±11 beats per minute was 
recorded. CS and MSCT results are listed in Table 2. The average CS was 325±751 
Agatston units. A CS >400 was present in 113 (22%) patients and CS was normal or 
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≤400 in 404 patients (78%). A CS >1000 was observed in 47 (9%) patients, while a CS 
≤1000 was observed in the remaining 470 patients (91%). During the contrast enhanced 
helical scan, a completely normal MSCT examination was observed in 155 (30%) of 
patients. Atherosclerosis, both mild (<50% stenosis) and significant (≥50% stenosis), 
was observed in 362 (70%). Significant CAD with lesions ≥50% stenosis was observed 
in 158 (31%) patients. Non-calcified plaques were observed in 130 patients (25%), 
mixed plaques in 204 patients (40%), and calcified plaques in 270 patients (52%). 
The results of MSCT in relation to MPI are illustrated in Figure 1. This figure illustrates 
the complementary value of MSCT and MPI. Only approximately 50% of patients with a 
significant lesion (≥50% stenosis) showed a perfusion defect on MPI (SSS ≥4). 
Importantly, a significant stenosis was observed in 22% of patients with normal 
perfusion on MPI (SSS<4). 
 
Follow-up results 
Of the cohort of 517 patients, 35 (6.8%) were lost to follow-up, while 43 (8.3%) patients 
underwent early revascularization (within 60 days of MSCT or MPI). In the remaining 
439 patients the median follow-up time achieved was 672 days (25-75th percentile: 420-
896). During this time period an event occurred in 23 patients (5.2%). Death by any 
cause occurred in 8 patients (1.8%); in 2 the cause of death could be ascertained as 
cardiac. Non-fatal myocardial infarction occurred in 8 patients (1.8%) and 7 patients 
(1.6%) were hospitalized due to unstable angina pectoris. 
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Univariate and multivariate analysis 
Baseline univariate predictors of events are listed in Table 3. CS, MSCT and MPI were 
significant univariate predictors of events. Both CS >400 and CS >1000 were significant 
predictors. When regarding the MSCT results on a patient level, the presence of 
significant CAD (≥50% stenosis) was a strong significant predictor (hazard ratio 3.683 
(95%-confidence interval (95%-CI): 1.611-8.420)), whereas the presence of any 
atherosclerosis was not (hazard ratio 3.087 (95%-CI: 0.917-10.388). Importantly, plaque 
composition on MSCT was also identified as a predictor of events. On a patient level, 
the presence of ≥2 segments with non-calcified plaque (n=65) (hazard ratio 5.0 (95%-
CI: 2.2-11.7)) or ≥3 segments with mixed plaque (n=68) (hazard ratio 3.5 (hazard ratio 
(95%-CI: 1.5-8.1) were both significant predictors of events. Of the MPI variables, the 
SSS ≥4 was the strongest significant predictor of events (hazard ratio 4.0, 95% CI 1.7-
9.3). 
After univariate analysis multivariate models were created for both MSCT and 
MPI correcting for baseline risk factors. MSCT (≥50% stenosis) remained a significant 
predictor when corrected for CS > 400 or CS > 1000. However CS > 400 and CS > 
1000 did not reach statistical significance. MPI also remained a significant predictor 
when corrected for CS > 400 or CS > 1000. In this model, CS > 1000 however also 
remained a significant independent predictor of events.  
Subsequently, several multivariate models were created to assess the 
independent predictive value of different MSCT variables, corrected for MPI and 
baseline risk factors. On a patient level, no independent prognostic value over MPI and 
baseline risk factors was observed for the presence of any atherosclerosis on MSCT. In 
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contrast, the observation of significant CAD on MSCT was however shown to provide 
independent prognostic value over MPI. When regarding plaque composition only the 
presence of 2 or more segments with non-calcified plaque was an independent 
significant predictor. Importantly, MPI remained an independent significant predictor of 
events in each multivariate model. 
To assess the incremental prognostic value of these MSCT variables over 
baseline clinical variables and MPI, global chi-square scores were calculated. The 
results of this analysis are presented in Figure 4. This figure shows that information on 
the presence of significant stenosis obtained by MSCT has incremental prognostic 
value to both baseline clinical variables alone and baseline clinical variables and MPI 
combined. Finally the addition of non-calcified plaque on a patient basis resulted in 
further enhancement of risk stratification incremental to the combination of clinical 
variables, MPI, and significant stenosis on MSCT. 
 
Event rates 
The Kaplan-Meier survival curves in Figures 2 and 3 illustrate the different survival rates 
of the MPI and MSCT test outcomes both for the composite endpoint of all cause 
mortality, non-fatal myocardial infarction and unstable angina requiring revascularization 
(Log Rank p-value <0.001) as well as for the combined hard endpoint of all cause 
mortality and non-fatal myocardial infarction (Log Rank p-value <0.05). The annualized 
event rate (annualized event rate for hard events between parentheses) in patients with 
a normal MPI examination (SSS <4) was 1.5% (1.1%); the annualized event rate in 
patients with an abnormal MPI (SSS ≥4) was 6.0% (3.8%). The annualized event rate in 
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patients with none or mild CAD (MSCT <50% stenosis) was 3.0% (1.8%). When these 
patients were further divided into patients with mild atherosclerosis and patients without 
any evidence of atherosclerosis, the annualized event rates were 2.0% (1.4%), and 
1.1% (0.3%) respectively. The annualized event rate for patients with a significant 
stenosis (≥50%) on MSCT was 6.3% (4.8%). When regarding plaque composition, the 
annualized event rate in patients with 2 or more segments with non-calcified plaque was 
8.4% (6.7%) compared to 1.9% (1.2%) in patients with no or less than 2 segments with 
non-calcified plaque. 
Combined use of MSCT and MPI resulted in significantly improved prediction of 
the composite hard endpoint of all cause mortality and non-fatal myocardial infarction 
(Log rank test p-value <0.005), as illustrated in the Kaplan-Meier survival curve in 
Figure 5. In patients with none or mild CAD (MSCT <50% stenosis) and a normal MPI 
(SSS <4) (n=256) the annualized event rate (annualized hard event rate in parenthesis) 
was 1.0% (0.6%). In patients with none or mild CAD (MSCT <50% stenosis) but an 
abnormal MPI (SSS ≥4) (n=72), the annualized event rate increased to 3.7% (2.2%), 
whereas patients with significant CAD (MSCT ≥50% stenosis) and a normal MPI (SSS 
<4) (n=57) were associated with an annualized event rate of 3.8% (3.8%). Interestingly, 
the event rates between patients with none or mild CAD (<50%) stenosis and an 
abnormal MPI and patients with significant CAD (MSCT ≥50% stenosis) did not differ 
significantly. In patients with both significant CAD (MSCT ≥50% stenosis) and an 
abnormal MPI (SSS <4) (n=54), the annualized event rate was 9.0% (6.0%). In these 
patients the addition of plaque composition (presence of 2 or more segments with non-
calcified plaque (n=20)) resulted in the highest event rate 10.8% (8.2%). 
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Discussion 
 
The main finding of the current study is that when used in combination with MPI, MSCT 
not only provides complementary information about the presence, extent, and 
composition of atherosclerosis, but importantly, also results in improved risk 
stratification as compared to the use of MPI alone. 
 
Risk stratification with MPI 
A wealth of data have been published on the diagnostic accuracy and prognostic value 
of MPI.(11-16) In an extensive review of the available literature a low risk scan was 
associated with a low annualized hard event rate (cardiac death and non-fatal 
myocardial infarction) of 0.6% in a population of 69,655 patients.(17) In a recent meta-
analysis, Metz et al specifically focused on the prognostic value of a normal MPI.(18) 
The pooled summary absolute event rate in their study was 1.21 (95%-CI: 0.98-1.48) for 
the occurrence of cardiac death and non-fatal myocardial infarction. The slightly higher 
absolute hard event rate in the current study (2.2%) may have been caused by the 
inclusion of all cause mortality, and the fact that the majority of patients underwent 
pharmacological testing.(17, 19). Importantly, event rates were significantly higher in 
patients with abnormal MPI (SSS ≥4), in line with the previous literature.(17)  
 
Risk stratification with MSCT 
While MSCT coronary angiography is a relatively new technique, a considerable 
amount of evidence is available with calcium scoring.(20-27) Moreover, in a systematic 
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review of the available literature (n=27,622 patients) the presence of any coronary 
artery calcium was shown to confer a 4-fold increased risk of cardiac death or 
myocardial infarction (p<0.0001) as compared to the absence of coronary artery 
calcifications.(24) In contrast, an extremely low event rate of 0.4% was observed in 
patients without any coronary artery calcium.  
Only limited data are available on the prognostic value of anatomic imaging with 
MSCT coronary angiography.(28-30) In the present study, annual hard event rates of 
0.3%, 2.0%, and 4.8% were observed in patients with respectively completely normal, 
non-significant and significant CAD on MSCT. Min et al evaluated 1,127 patients 
undergoing 16-slice MSCT with a mean follow-up of 15.3±3.9 months. In line with our 
study, event rates for all cause mortality ranging between 0.3% for none or mild 
atherosclerosis (stenosis <50%) to 15% for mild to moderate left main disease were 
observed in a period of 2 years.(29)  
Currently one previous study by Pundziute et al. has addressed the prognostic 
value of plaque components assessed by MSCT.(30) The number of mixed plaques 
was a significant predictor when corrected for baseline clinical variables. In the current 
study only non-calcified plaque remained an independent predictor of events. The 
discrepancy between the current results and the study by Pundziute et al. may be 
explained by differences in the studied patient populations as well as the use of 
optimized cutoffs and correction for MPI results in the current study. 
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Combination of MSCT and MPI 
In previous studies, the prognostic value of anatomic imaging using calcium scoring in 
relation to MPI has been addressed.(31-34) Recently, Schenker et al showed that the 
risk of all cause mortality and myocardial infarction increased with increasing CS, both 
in patients with normal and in patients with abnormal perfusion on MPI.(34) The present 
study is the first to address the incremental prognostic value of MSCT when used in 
combination with MPI. Previous studies have shown that MPI provides incremental 
prognostic information over invasive coronary angiography.(4, 5) Vice versa, the current 
study has revealed that the anatomic information on MSCT is not only an independent 
predictor of events but also provides incremental prognostic information over baseline 
clinical variables and MPI, particularly in patients with a normal MPI. Although several 
MSCT variables were able to provide prognostic information, on a patient level the 
presence of significant CAD (≥50% stenosis) was identified as a robust independent 
predictor. This is an important finding as diagnostic MSCT examinations are often 
graded in this manner. In addition to stenosis severity, plaque composition was also 
identified to further enhance risk stratification. Indeed, the presence of non-calcified 
plaques provided incremental prognostic information over baseline clinical variables, 
MPI, and significant CAD on MSCT. This finding suggests that potentially assessment 
of plaque composition on MSCT may provide clinically relevant information in addition to 
stenosis severity. 
 
Study limitations 
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Even though the diagnostic accuracy of MSCT is high, images are still uninterpretable in 
a small percentage of patients. It is however anticipated that the amount of 
uninterpretable studies will continue to decrease with newer generation scanners.(35, 
36) In contrast, none of the SPECT examinations were uninterpretable in this study.  
Another potential limitation is that the MSCT studies were evaluated visually; no 
validated accurate quantitative algorithms are currently available. In the current study a 
composite endpoint including all cause mortality was used, which is not a direct cardiac 
endpoint. An important advantage of all cause mortality however is the fact that it is not 
affected by verification bias.(37) Furthermore most deaths in adults are linked to 
cardiovascular disease. All cause mortality is therefore a commonly used endpoint 
allowing comparison of the current results to previous investigations.(21, 26, 29, 34) 
Finally, the radiation burden associated with combined MSCT and MPI imaging is a 
limitation. However the radiation dose can decrease significantly when using dedicated 
dose reduction MSCT acquisition techniques that have recently become available.(38-
41) 
 
Conclusion 
MSCT is an independent predictor of events and provides incremental prognostic value 
to MPI. Furthermore, addition of plaque composition to stenosis severity was shown to 
provide incremental prognostic information. The results of this study suggest that 
combined anatomical and functional assessment may allow improved risk stratification.
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Figure legends 
Figure 1: Pie charts depicting the relationship between the anatomic information 
obtained by MSCT and the functional information from MPI. 
Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography; 
SSS: summed stress score. 
 
Figure 2 A: Kaplan-Meier curves for all events (all cause mortality, non-fatal infarction, 
and unstable angina requiring revascularization) in patients with a normal MPI (SSS<4) 
or an abnormal MPI (SSS≥4). 
Abbreviations: MPI: myocardial perfusion imaging; SSS: summed stress score. 
 
Figure 2 B: Kaplan-Meier curves for hard events (all cause mortality and non-fatal 
infarction) in patients with a normal MPI (SSS<4) or an abnormal MPI (SSS≥4). 
Abbreviations: MPI: myocardial perfusion imaging; SSS: summed stress score. 
 
Figure 3 A:  Kaplan-Meier curves for all events (all cause mortality, non-fatal infarction, 
and unstable angina requiring revascularization) in patients with no CAD (MSCT 
normal), mild CAD (MSCT <50% stenosis) or significant CAD (MSCT ≥50% stenosis). 
Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography. 
 
Figure 3 B:  Kaplan-Meier curves for hard events (all cause mortality and non-fatal 
infarction) in patients with no CAD (MSCT normal), mild CAD (MSCT <50% stenosis) or 
significant CAD (MSCT ≥50% stenosis). 
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Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography. 
 
Figure 4: Bar graphs illustrating the incremental prognostic value (depicted by chi-
square value on the y-axis) of MSCT. The addition of MSCT provides incremental 
prognostic information to baseline clinical variables and MPI. Furthermore the addition 
of non-calcified plaque on MSCT (≥2 segments with non-calcified plaque) results in 
further incremental prognostic information over baseline clinical variables, MPI, and 
significant CAD (≥50% stenosis) on MSCT. 
 
Figure 5:  Kaplan-Meier curves for hard events (all cause mortality and non-fatal 
infarction) in patients with a normal MPI (SSS <4) and none or mild CAD (<50% 
stenosis) on MSCT, in patients with an abnormal MPI (SSS ≥ 4) and with none or mild 
CAD (<50% stenosis) on MSCT, in patients with a normal MPI (SSS <4) and significant 
CAD (MSCT ≥50% stenosis), and finally in patients with an abnormal MPI (SSS ≥ 4) 
and significant CAD (MSCT ≥50% stenosis). 
Abbreviations: CAD: coronary artery disease; MPI: myocardial perfusion imaging; 
MSCT: multi-slice computed tomography; SSS: summed stress score. 
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Table 1. Patient characteristics  
 Total 
 
n = 517 
Gender (male)  303 (59%) 
Age (yrs) 59±11 
Risk Factors  
  Diabetes 156 (30%) 
  Hypertension 290 (56%) 
  Hypercholesterolemia 209 (40%) 
  Family history CAD 191 (37%) 
  Current Smoking 154 (30%) 
  Obesity (BMI ≥ 30) 111 (22%) 
Pre-test likelihood of CAD  
  Low 113 (22%) 
  Intermediate 336 (65%) 
  High 68 (13%) 
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Abbreviations: CAD: coronary artery disease; CS: calcium score; SDS: summed difference score; SSS: 
summed stress score.  
Table 2. Imaging results  
Calcium Score  Patients (%) 
  CS > 400 113 (22%) 
  CS > 1000 47 (9%) 
MSCT   
  Atherosclerosis 362 (70%) 
  Significant CAD  158 (31%) 
  Patients with non-calcified plaques 130 (25%) 
  Patients with mixed plagues 204 (40%) 
  Patients with calcified plaques 270 (52%) 
MPI  
  SSS <4 (normal) 349 (67%) 
  SSS 4-7 104 (20%) 
  SSS 8-12 44 (9%) 
  SSS ≥ 13 20 (4%) 
  SDS 0-1 378 (73%) 
  SDS 2-3 72 (14%) 
  SDS ≥ 4 67 (13%) 
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Abbreviations: CAD: coronary artery disease; CS: calcium score; MSCT: multi-slice computed 
tomography; SDS: summed difference score; SSS: summed stress score. 
Table 3. Univariate predictors of events   
 HR (95%-CI) p-value 
Calcium Score   
  CS > 400 3.007 (1.318-6.860) 0.009 
  CS > 1000 3.752 (1.392-10.114) 0.009 
MSCT    
  Atherosclerosis 3.087 (0.917-10.388) 0.069 
  Significant CAD 3.683 (1.611-8.420) 0.002 
  ≥2 non-calcified plaques 5.0 (2.2-11.7) <0.001 
  ≥3 mixed plagues 3.5 (1.5-8.1) <0.005 
  ≥4 calcified plaques 1.5 (0.6-4.1) 0.409 
MPI   
  SSS ≥ 2 3.500 (1.513-8.094) 0.003 
  SSS ≥ 4 4.029 (1.742-9.319) 0.001 
  SSS ≥ 8 1.922 (0.653-5.656) 0.236 
  SDS ≥ 2 1.853 (0.783-4.381) 0.160 
  SDS ≥ 4 2.142 (0.724-6.336) 0.169 
 36
Figure 1: Pie charts depicting the relationship between the anatomic information 
obtained by MSCT and the functional information from MPI. 
Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography; 
SSS: summed stress score 
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Figure 2 A: Kaplan-Meier curves for all events (all cause mortality, non-fatal infarction, and unstable angina requiring 
revascularization) in patients with a normal MPI (SSS<4) or an abnormal MPI (SSS≥4). 
Abbreviations: MPI: myocardial perfusion imaging; SSS: summed stress score. 
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Figure 2 B: Kaplan-Meier curves for hard events (all cause mortality and non-fatal infarction) in patients with a normal 
MPI (SSS<4) or an abnormal MPI (SSS≥4). 
Abbreviations: MPI: myocardial perfusion imaging; SSS: summed stress score. 
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Figure 3 A:  Kaplan-Meier curves for all events (all cause mortality, non-fatal infarction, and unstable angina requiring 
revascularization) in patients with no CAD (MSCT normal), mild CAD (MSCT <50% stenosis) or significant CAD (MSCT 
≥50% stenosis). 
Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography. 
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Figure 3 B:  Kaplan-Meier curves for hard events (all cause mortality and non-fatal infarction) in patients with no CAD 
(MSCT normal), mild CAD (MSCT <50% stenosis) or significant CAD (MSCT ≥50% stenosis). 
Abbreviations: CAD: coronary artery disease; MSCT: multi-slice computed tomography. 
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Figure 4: Bar graphs illustrating the incremental prognostic value (depicted by chi-square value on the y-axis) of MSCT. 
The addition of MSCT provides incremental prognostic information to baseline clinical variables and MPI. Furthermore the 
addition of non-calcified plaque on MSCT (≥2 segments with non-calcified plaque) results in further incremental prognostic 
information over baseline clinical variables, MPI, and significant CAD (≥50% stenosis) on MSCT. 
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Figure 5:  Kaplan-Meier curves for hard events (all cause mortality and non-fatal infarction) in patients with a normal MPI 
(SSS <4) and none or mild CAD (<50% stenosis) on MSCT, in patients with an abnormal MPI (SSS ≥ 4) and with none or 
mild CAD (<50% stenosis) on MSCT, in patients with a normal MPI (SSS <4) and significant CAD (MSCT ≥50% stenosis), 
and finally in patients with an abnormal MPI (SSS ≥ 4) and significant CAD (MSCT ≥50% stenosis). 
Abbreviations: CAD: coronary artery disease; MPI: myocardial perfusion imaging; MSCT: multi-slice computed 
tomography; SSS: summed stress score. 
 
 
 
